Status:
COMPLETED
The Effectiveness of Breathing Therapy in Patients With Schizophrenia
Lead Sponsor:
Ataturk University
Conditions:
Breathing Therapy
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study aimed to determine the effects of breathing therapies on sleep disturbances and fatigue in patients with schizophrenia.The study will be conducted at a CMHC in Ağrı province between May and...
Detailed Description
Study data were collected by the researcher through face-to-face interviews. The study included individuals diagnosed with schizophrenia who met the inclusion criteria (registration in a CMHC, having ...
Eligibility Criteria
Inclusion
- Being registered with a CMHC
- Being diagnosed with schizophrenia
- Being between the ages of 18 and 60
- Being willing to participate in the study
- Being open to communication and cooperation
- Being in remission
Exclusion
- Not being open to communication and cooperation
Key Trial Info
Start Date :
April 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT07150507
Start Date
April 29 2022
End Date
May 15 2023
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ataturk University Faculty of Nursing
Erzurum, Yakutiye, Turkey (Türkiye)